SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-026035
Filing Date
2021-05-10
Accepted
2021-05-10 16:05:31
Documents
14
Period of Report
2021-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aveo-8k_20210510.htm   iXBRL 8-K 41705
2 EX-99.1 aveo-ex991_6.htm EX-99.1 239433
3 GRAPHIC ged1ustbqnf2000001.jpg GRAPHIC 4922
  Complete submission text file 0001564590-21-026035.txt   436353

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aveo-20210510.xsd EX-101.SCH 5792
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE aveo-20210510_lab.xml EX-101.LAB 18717
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aveo-20210510_pre.xml EX-101.PRE 11185
7 EXTRACTED XBRL INSTANCE DOCUMENT aveo-8k_20210510_htm.xml XML 3409
Mailing Address 30 WINTER STREET BOSTON MA 02108
Business Address 30 WINTER STREET BOSTON MA 02108 857-400-0101
AVEO PHARMACEUTICALS, INC. (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 043581650 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34655 | Film No.: 21907067
SIC: 2834 Pharmaceutical Preparations